A novel role for serotonin in heart

Trends in Cardiovascular Medicine

Volumn 11, Issue 8, 2001, Pages 329-335

  Nebigil, Canan G ^a   Maroteaux, Luc ^a,b  

^a CNRS   (France)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ERGOT DERIVATIVE; NORFENFLURAMINE; SEROTONIN; SEROTONIN 2B RECEPTOR; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG;

CARDIOVASCULAR FUNCTION; CARDIOVASCULAR RISK; CELL FUNCTION; CELL JUNCTION; CELL STRUCTURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EMBRYO DEATH; EMBRYO DEVELOPMENT; GENE INACTIVATION; GENETIC SUSCEPTIBILITY; HEART DEVELOPMENT; HEART DILATATION; HEART MUSCLE CELL; HEART MUSCLE CONTRACTILITY; HUMAN; NEWBORN DEATH; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SHORT SURVEY; SIGNAL TRANSDUCTION; SYSTOLE; TISSUE DIFFERENTIATION;

EID: 0035203568     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1050-1738(01)00135-9     Document Type: Review

References (42)

1. Enhanced Galphaq signaling: A common pathway mediates cardiac hypertrophy and apoptotic heart failure
2. G-proteins in growth and apoptosis: Lessons from the heart
3. Transgenic mice with cardiac overexpression of alpha1B-adrenergic receptors. In vivo alpha1-adrenergic receptor-mediated regulation of beta-adrenergic signaling
4. The cellular basis of dilated cardiomyopathy in humans
5. Immunohistochemical localisation of the serotonin 5-HT2B receptor in mouse gut, cardiovascular system, and brain
6. 5-HT2B receptor-mediated serotonin morphogenetic functions in mouse cranial neural crest and myocardiac cells
7. Transgenic Galphaq overexpression induces cardiac contractile failure in mice
8. Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice
9. Dilated and failing cardiomyopathy in bradykinin B(2) receptor knockout mice
10. Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine
11. Serotonin and the heart
12. Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block
13. IUPHAR classification of receptors for 5-hydroxytryptamine (serotonin)
14. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1
15. Neurotransmitters as growth regulatory signals: Role of receptors and second messengers
16. Expression of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors in the mouse embryo
17. The 5-HT2B receptor gene maps to 2q36.3-2q37.1
18. Requirement for neuregulin receptor erbB2 in neural and cardiac development
19. Neuregulins in development
20. PDZ-dependent activation of nitric-oxide synthases by the serotonin 2B receptor
21. Cellular versus myocardial basis for the contractile dysfunction of hypertrophied myocardium
22. Cardiac hypertrophy: Sorting out the circuitry
23. Rescue of the cardiac defect in ErbB2 mutant mice reveals essential roles of ErbB2 in peripheral nervous system development
24. Serotonin 2B receptor is required for heart development
25. 5-Hydroxytryptamine 2B receptor regulates cell-cycle progression: Cross talk with tyrosine kinase pathways
26. Ablation of serotonin 5-HT2B receptors in mice leads to abnormal cardiac structure and function
27. Embryonic cardiomyocyte hypoplasia and craniofacial defects in G alpha q/G alpha 11-mutant mice
28. Functional characterization of agonists at recombinant human 5-HT2A, 5-HT2B and 5-HT2C receptors in CHO-K1 cells
29. Developmental defects in mouse embryos lacking N-cadherin
30. Carcinoid heart disease. Correlation of high serotonin levels with valvular abnormalities detected by cardiac catheterization and echocardiography
31. Evidence for possible involvement of 5-HT(2B) receptors in the cardiac valvulopathy associated with fenfluramine and other serotonergic medications
32. Serotonin deficiency in phenylketonuria embryopathy
33. Impairment of the myocardial ultrastructure and changes of the cytoskeleton in dilated cardiomyopathy
34. How safe are serotonin reuptake inhibitors for depression in patients with coronary heart disease?
35. Serotonin as a regulator of craniofacial morphogenesis: Site specific malformations following exposure to serotonin uptake inhibitors
36. Familial dilated cardiomyopathy locus maps to chromosome 2q31
37. N-cadherin involvement in cardiac myocyte interaction and myofibrillogenesis
38. Cross-talk between 5-hydroxytryptamine receptors in a serotonergic cell line. Involvement of arachidonic acid metabolism
39. Serotonin receptors as cardiovascular targets
40. Chronic pressure overload cardiac hypertrophy and failure in guinea pigs: III. Intercalated disc remodeling
41. Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene
42. Serotonin and cardiac morphogenesis in the mouse embryo